Actions of insulin beyond glycemic control: A perspective on insulin detemir

Advances in Therapy

Volumn 24, Issue 4, 2007, Pages 868-882

  Tibaldi, Joseph ^a,b  

^a FLUSHING HOSPITAL MEDICAL CENTER   (United States)

^b Queens Endocrine and Diabetes Associates   (United States)

Author keywords

Albumin binding; Brain; Glycemic control; Insulin detemir; Weight gain

Indexed keywords

ALBUMIN; GLUCOSE TRANSPORTER 4; INSULIN; INSULIN ASPART; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN LISPRO; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; ISOPHANE INSULIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; ANTIDIABETIC AGENT; DRUG DERIVATIVE;

BODY WEIGHT; CLINICAL TRIAL; DIET RESTRICTION; DRUG CLEARANCE; DRUG INHIBITION; DRUG MECHANISM; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG RECEPTOR BINDING; ENERGY EXPENDITURE; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; RECEPTOR AFFINITY; REVIEW; SIDE EFFECT; SIGNAL TRANSDUCTION; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN; ANIMAL; BRAIN; LIVER; METABOLISM; PHYSIOLOGY;

ANIMALS; BRAIN; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; LIVER; OBESITY; SIGNAL TRANSDUCTION; WEIGHT GAIN;

EID: 38449115454     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02849980     Document Type: Review

References (71)